发明名称 |
Chemica compounds |
摘要 |
Disclosed are compounds of Formula I, Formula II, and Formula III. Also disclosed are salts of the compounds, pharmaceutical composition comprising the compounds or salts, and methods for treating HCV infection by administration of the compounds or salts.; |
申请公布号 |
US8889726(B2) |
申请公布日期 |
2014.11.18 |
申请号 |
US201214233396 |
申请日期 |
2012.08.06 |
申请人 |
GlaxoSmithKline LLC |
发明人 |
Baskaran Subramanian;Grimes Richard Martin;Kazmierski Wieslaw Mieczyslaw;Leivers Martin Robert |
分类号 |
A61K31/4178;C07D233/54;C07D403/14;C07D409/14;C07D405/14 |
主分类号 |
A61K31/4178 |
代理机构 |
|
代理人 |
Brink Robert H. |
主权项 |
1. A compound or pharmaceutically acceptable salt of Formula I; wherein each R is independently —CH(R1)—NH—C(O)—OR2; wherein each R1 is independently —CH(OH)—CH3 or —CH(OCH3)—CH3; and
each R2 is independently C1-3alkyl. |
地址 |
Philadelphia PA US |